TrialAmerican journal of kidney diseases : the official journal of the National Kidney Foundation2023

Lumasiran for Advanced Primary Hyperoxaluria Type 1: Phase 3 ILLUMINATE-C Trial.

Mini Michael et al.PubMed ↗Publisher ↗

No numbers read from the abstract.